RGEN - Repligen Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
+0.12 (+0.20%)
As of 10:04AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close60.19
Bid60.16 x 800
Ask60.37 x 800
Day's Range60.00 - 60.53
52 Week Range31.46 - 70.50
Avg. Volume387,303
Market Cap2.645B
Beta (3Y Monthly)0.84
PE Ratio (TTM)118.25
EPS (TTM)0.51
Earnings DateFeb 21, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est64.63
Trade prices are not sourced from all markets
  • GlobeNewswire4 days ago

    Repligen to Report Fourth Quarter and Full Year 2018 Financial Results

    WALTHAM, Mass., Feb. 15, 2019 -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its fourth quarter and full year 2018 financial results on.

  • Markit11 days ago

    See what the IHS Markit Score report has to say about Repligen Corp.

    Repligen Corp NASDAQ/NGS:RGENView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is moderate * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is moderate for RGEN with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding RGEN totaled $1.18 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Is Repligen Corporation’s (NASDAQ:RGEN) Liquidity Good Enough?
    Simply Wall St.20 days ago

    Is Repligen Corporation’s (NASDAQ:RGEN) Liquidity Good Enough?

    Mid-caps stocks, like Repligen Corporation (NASDAQ:RGEN) with a market capitalization of US$2.4b, aren’t the focus of most investors who prefer to direct their investments towards either large-cap or small-cap stocks. Read More...

  • ACCESSWIRE22 days ago

    Today's Research Reports on Trending Tickers: Incyte and Repligen

    NEW YORK, NY / ACCESSWIRE / January 28, 2019 / U.S. equities closed higher on Friday as companies continue to report upbeat earnings and Trump and the Democrats agreed to reopen the government until Feb. ...

  • Motley Fool25 days ago

    3 Pick-and-Shovel Biotechnology Stocks

    These biotech suppliers have performed extremely well for investors. Here's why each of them is poised for prosperity.

  • Motley Fool26 days ago

    How to Play It Safe in Biotech

    Risk-averse investors might be surprised how safe some of these companies are in one of the most volatile sectors on the market.

  • GlobeNewswire27 days ago

    Consolidated Research: 2019 Summary Expectations for Post, Westlake Chemical, Repligen, Weingarten Realty Investors, AptarGroup, and At Home Group — Fundamental Analysis, Key Performance Indications

    NEW YORK, Jan. 23, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • MoneyShowlast month

    Top Picks 2019- Repligen RGEN

    Repligen (RGEN) is a pure-play supplier of bioprocessing technologies. It is a market leader in proteins (over 95% market share), where it has a near monopoly, explains Tyler Laundon, editor of Cabot Small-Cap Confidential.

  • GlobeNewswire2 months ago

    Repligen to Present at 37th Annual J.P. Morgan Healthcare Conference

    WALTHAM, Mass., Jan. 03, 2019 -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will.

  • Is Repligen Corporation (RGEN) A Good Stock To Buy?
    Insider Monkey2 months ago

    Is Repligen Corporation (RGEN) A Good Stock To Buy?

    Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us with significant returns as well. Many hedge funds, like Paul Singer’s Elliott Management, are pretty secretive, but we can still get some insights by analyzing […]

  • Have Insiders Been Selling Repligen Corporation (NASDAQ:RGEN) Shares This Year?
    Simply Wall St.2 months ago

    Have Insiders Been Selling Repligen Corporation (NASDAQ:RGEN) Shares This Year?

    We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that there are more than a few examples Read More...

  • ANIK vs. RGEN: Which Stock Should Value Investors Buy Now?
    Zacks2 months ago

    ANIK vs. RGEN: Which Stock Should Value Investors Buy Now?

    ANIK vs. RGEN: Which Stock Is the Better Value Option?

  • Based On Its ROE, Is Repligen Corporation (NASDAQ:RGEN) A High Quality Stock?
    Simply Wall St.3 months ago

    Based On Its ROE, Is Repligen Corporation (NASDAQ:RGEN) A High Quality Stock?

    One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return Read More...

  • Trump Trade Comments Boost Dow Jones; These 6 Growth Stocks Take Market Helm
    Investor's Business Daily3 months ago

    Trump Trade Comments Boost Dow Jones; These 6 Growth Stocks Take Market Helm

    The Dow Jones industrial average is leading another rebound on Wall Street following a sharp pullback in recent days. Chipotle, Attunity, Repligen and McDonald's are acting bullishly.

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of RGEN earnings conference call or presentation 1-Nov-18 12:30pm GMT

    Q3 2018 Repligen Corp Earnings Call

  • Highly Rated 'Surgeon' For Biologic-Drug Makers Soars 85% In 2018
    Investor's Business Daily3 months ago

    Highly Rated 'Surgeon' For Biologic-Drug Makers Soars 85% In 2018

    Repligen stock is on a rampage this year as it outperforms broad medical-products stocks. The bioprocessing firm has completely transformed, its CEO says.

  • 3 Growth Stocks for In-the-Know Investors
    Motley Fool4 months ago

    3 Growth Stocks for In-the-Know Investors

    An underrated biotech, a boring industrials play, and an intriguing cloud company: Here's why these growth stocks deserve your attention.